Taiwan FDA registration e5deb9fe14acc1a6365c6b808e3b5cdf

"Siemens" basic phosphoric acid per (AMP method) reagent set

TW: “西門子”鹼性磷酸每(AMP法)試劑組
Taiwan flagTaiwan·Risk Class 2·SIEMENS HEALTHCARE DIAGNOSTICS INC.;; RANDOX LABORATORIES LTD.·Registered Jan 22, 2008 – Jan 22, 2018Cancelled
Registration details
Analysis ID
e5deb9fe14acc1a6365c6b808e3b5cdf
Customs Code
DHA00601893101
Company information
Manufacturer Country
United Kingdom;;United States
Authorized Representative
SIEMENS HEALTHCARE LIMITED
Product details
Intended Use
For in vitro diagnostics. The activity of basic phosphoric acid in human serum and plasma was quantitatively determined on the ADVIA fully automated chemical analysis system.
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A.1050 Alkaline phosphatase or isoenzyme testing system
Import Information
import
Dates and status
Registration Date
Jan 22, 2008
Expiry Date
Jan 22, 2018
Cancellation Date
Nov 04, 2019
Cancellation information
Status
Logged out
Reason
許可證已逾有效期
About this record

Access comprehensive regulatory information for "Siemens" basic phosphoric acid per (AMP method) reagent set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number e5deb9fe14acc1a6365c6b808e3b5cdf and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC.;; RANDOX LABORATORIES LTD.. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices